Pine River Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-2,039,192
| Closed | -$88.1M | – | 798 |
|
|
2015
Q3 | $88.1M | Buy |
2,039,192
+1,917,828
| +1,580% | +$82.9M | 1.13% | 10 |
|
|
2015
Q2 | $5.13M | Buy |
+121,364
| New | +$5.13M | 0.06% | 192 |
|
|
2015
Q1 | – | Sell |
-29,300
| Closed | -$987K | – | 758 |
|
|
2014
Q4 | $987K | Sell |
29,300
-2,700
| -8% | -$91K | 0.01% | 424 |
|
|
2014
Q3 | $1.12M | Hold |
32,000
| – | – | 0.01% | 455 |
|
|
2014
Q2 | $1.05M | Buy |
32,000
+10,800
| +51% | +$355K | 0.02% | 393 |
|
|
2014
Q1 | $781K | Buy |
21,200
+11,700
| +123% | +$431K | 0.01% | 312 |
|
|
2013
Q4 | $365K | Buy |
9,500
+1,300
| +16% | +$49.9K | ﹤0.01% | 397 |
|
|
2013
Q3 | $225K | Sell |
8,200
-1,900
| -19% | -$52.1K | ﹤0.01% | 303 |
|
|
2013
Q2 | $212K | Buy |
+10,100
| New | +$212K | ﹤0.01% | 293 |
|